Revisiting Treatment of Metastatic Urothelial Cancer: Where Do Cisplatin and Platinum Ineligibility Criteria Stand?

MLA

Moussa, Mohammad Jad, et al. “Revisiting Treatment of Metastatic Urothelial Cancer: Where Do Cisplatin and Platinum Ineligibility Criteria Stand?” Biomedicines, vol. 12, no. 3, Mar. 2024, p. 519. EBSCOhost, https://doi.org/10.3390/biomedicines12030519.

APA

Moussa, M. J., Campbell, M. T., & Alhalabi, O. (2024). Revisiting Treatment of Metastatic Urothelial Cancer: Where Do Cisplatin and Platinum Ineligibility Criteria Stand? Biomedicines, 12(3), 519. https://doi.org/10.3390/biomedicines12030519

Chicago

Moussa, Mohammad Jad, Matthew T. Campbell, and Omar Alhalabi. 2024. “Revisiting Treatment of Metastatic Urothelial Cancer: Where Do Cisplatin and Platinum Ineligibility Criteria Stand?” Biomedicines 12 (3): 519. doi:10.3390/biomedicines12030519.